Comments are closed.
Rob Cox and Robert Cyran discuss Wall Street's desire for Pfizer to split – and why the company is taking so long.
Antony Currie and Rob Cox explain how the $160 bln pharma merger gets around recent U.S. attempts to stop inversion deals – and why it may prompt policymakers to reform the tax code.
Breakingviews columnists discuss UK regulators' tepid response to wrongdoing at the failed British mortgage giant and why thwacking the bosses now is too little, too late.
Breakingviews has published a selection of books for purchase and download.
Edited by Peter Thal Larsen and Quentin Webb
Edited by Richard Beales
View on mobile device
By Peter Thal Larsen
Read the e-book online
Download PDF (English)
Download PDF (Chinese) (点击下载电子书)
Visit the dedicated webpage (Breakingviews subscribers only)
Edited by Robert Cyran
Edited by John Foley